Commission action will be decisive for innovation
This article was originally published in Clinica
Executive Summary
The European Commission’s exploratory process on the future of the medical devices sector has begun and meetings are already underway. What subjects are likely to emerge as those chosen for further reflection? Commission expert Guilia del Brenna discusses the possibilities in the context of developments in the pharmaceutical sector